Making the decision to participate in a clinical trial is a very personal one. Some individuals do it because they have run out of options and want to try a new experimental treatment in the hope it might help their condition, while others do it because they want to do their part helping the clinical community move forward and potentially help cure many people down the line.
Clinical trials vary in time; in total a single clinical trial may take up to 15 years to complete, and some longitudinal studies ask the participant to stay in touch for follow up questions for a few years after their participation in the study is finished. Depending on the goal and the design of a clinical trial, volunteers may be asked to stay on site for a set amount of nights; this happens because the researchers might want to monitor the participant’s at different hours of the day or night.
In Michigan, the University of Michigan division of research has one of the largest clinical trial and research centers in the state, where interested volunteers can enroll in studies for healthy or non-healthy individuals. The Barbara Ann Karmanos cancer institute in Detroit, Michigan also offers clinical trials for many types of cancers for both healthy and non-healthy individuals.
Volunteers who decide to participate in a clinical trial may be compensated for their time and travel expenses during their participation in the study. The compensation will vary depending on the type of study and level of participation required from the volunteer.
Participating in a clinical trial is always completely voluntary. This means that nobody, regardless of their condition can be forced to participate nor can they be forced to continue participating in a trial if they wish to withdraw from the study. Non-healthy individuals who decide to enroll in a clinical trial after a suggestion from their doctor or to try an experimental treatment for their condition will never be denied care if they decide to drop out of the study.
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
on July 19, 2019 at 4:00 pm
Condition: Generalized LipodystrophyIntervention: Drug: MetreleptinSponsor: Aegerion Pharmaceuticals, Inc.Recruiting […]
A Study of Nivolumab and Ipilimumab in Untreated Patients With Stage 3 NSCLC That is Unable or Not Planned to be Removed by Surgery
on July 19, 2019 at 4:00 pm
Condition: Non-Small Cell Lung Cancer (NSCLC)Interventions: Drug: Nivolumab; Drug: Ipilimumab; Drug: DurvalumabSponsor: Bristol-Myers SquibbNot yet recruiting […]
A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee
on July 18, 2019 at 4:00 pm
Condition: Peripheral Arterial DiseaseIntervention: Device: MicroStent or percutaneous transluminal angioplasty (PTA)Sponsor: Micro Medical Solution, Inc.Not yet recruiting […]
Nerve Transfer After Spinal Cord Injury- Multi-center
on July 17, 2019 at 4:00 pm
Conditions: Tetraplegia; Spinal Cord Injuries; Quadriplegia FlaccidIntervention: Procedure: Surgery/Occupational TherapySponsors: Washington University School of Medicine; The University of Texas Health Science Center, Houston; Stanford University; University of Pennsylvania; […]
MVP RCT: Mind and Voice Project Randomized Control Trial
on July 15, 2019 at 4:00 pm
Conditions: Physical Health; Mental Health; Alcohol; Use, Problem; Interpersonal ViolenceInterventions: Other: Resource pamphlet; Behavioral: Remote TherapySponsor: University of MichiganNot yet recruiting […]
Blood-Flow Restriction Exercise Following a Knee Replacement
on July 12, 2019 at 4:00 pm
Conditions: Knee Injuries; Knee Osteoarthritis; Knee ArthritisIntervention: Other: B-FREESponsors: Michigan Technological University; Blue Cross Blue Shield of Michigan FoundationRecruiting […]
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
on July 10, 2019 at 4:00 pm
Conditions: Pediatric Epileptic Syndrome; Partial-onset SeizuresInterventions: Drug: Perampanel Oral Suspension; Drug: Perampanel TabletSponsor: Eisai Inc.Recruiting […]
Home-Based Fluid Status Monitoring in Heart Failure Patients
on July 9, 2019 at 4:00 pm
Condition: Heart FailureIntervention: Device: SOZO Bioimpedance Spectroscopy DeviceSponsor: ImpediMed LimitedRecruiting […]